Wednesday, March 31, 2010

Transrectal Ultrasound–Guided Transperineal Botulinum Toxin A Injection to the External Urethral Sphincter for Treatment of Detrusor External Sphincter Dyssynergia in Patients With Spinal Cord Injury

Volume 91, Issue 3, Pages 340-344 (March 2010)

Abstract 

Chen S-L, Bih L-I, Chen G-D, Huang Y-H, You Y-H, Lew HL. Transrectal ultrasound–guided transperineal botulinum toxin A injection to the external urethral sphincter for treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury.
Objective
To evaluate the effects of a single transrectal ultrasound (TRUS)–guided transperineal injection of botulinum toxin A (BTX-A) to the external urethral sphincter (EUS) for treating detrusor external sphincter dyssynergia (DESD).
Design
Descriptive study.
Setting
Rehabilitation hospital affiliated with a medical university.
Participants
Patients (N=18) with suprasacral spinal cord injury who had DESD confirmed on video-urodynamic study.
Interventions
A single dose of 100U BTX-A was applied into the EUS via TRUS-guided transperineal route injection.
Main Outcome Measures
Maximal detrusor pressure, detrusor leak-point pressure, integrated electromyography (iEMG), maximal pressure on static urethral pressure profilometry, and postvoiding residuals.
Results
There were significant reductions in iEMG (P=.008) and static (P=.012) and dynamic urethral pressure (P=.023), but not in detrusor pressure and detrusor leak-point pressure after treatment. Postvoiding residuals also significantly decreased in the first and second month after treatment (P<.012).
Conclusions
TRUS-guided transperineal injection of BTX-A has beneficial effects in treating DESD.
a Department of Urology, Chung Shan Medical University, Taichung, Taiwan
b Department of Physical Medicine and Rehabilitation, Chung Shan Medical University, Taichung, Taiwan
c Department of Obstetrics and Gynecology, Chung Shan Medical University, Taichung, Taiwan
d Chung Shan Medical University Hospital, School of Medicine, Chung Shan M.edical University, Taichung, Taiwan
e Department of Nursing, Taipei City Hospital, Zhongxiao Branch, Taipei, Taiwan
f Department of Physical Medicine and Rehabilitation Service, VA Boston Healthcare System, Boston, MA

Modular knee-ankle-foot orthosis for duchenne muscular dystrophy




Lightweight, modular knee-ankle-foot orthosis for duchenne muscular dystrophy: Design, development, and evaluation

PhD Diane M. TaktakaCorresponding Author Information, PhD Peter Bowkerb
Received 8 May 1995; accepted 3 July 1995.

Abstract 

Objective:
The study aimed to design and construct a modular system of knee-ankle-foot orthotics (KAFOs) that could be quickly and easily assembled and provided to children with Duchenne muscular dystrophy. A pilot study would then compare the modular orthotics with the childrens' existing devices.
Design:
Measurements from the legs of a consecutive sample of 26 Duchenne boys were taken to determine the sizing of the modular system. Nine boys with Duchenne muscular dystrophy were randomly selected to take part in a pilot study that focused on a comparison between their original and modular KAFOs of supply time, weight, energy expenditure during gait, gait speed, and ease of don/doff.
Setting:
The supply and fitting of the KAFOs can be done either in the hospital, clinic, or school.
Patients:
Boys with Duchenne muscular dystrophy, referred by the clinician for provision of KAFOs. Nine boys were approached to take part in the pilot study; all accepted. Their age range was 5 to 13 years.
Main Outcome Measures:
It is possible, by use of a modular KAFO system, to provide long leg orthoses to boys with Duchenne muscular dystrophy in approximately 1 hour.
Results:
The pilot study also showed that the modular KAFOs provided a 23% weight saving, resulting in a 10% energy saving during ambulation and an 8% increase in walking speed. They were easier to don/doff and were preferred by all involved.
No full text is available. To read the body of this article, please view the PDF online.